Theodore R Schroeder Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Theodore R Schroeder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Theodore R Schroeder. Theodore R Schroeder is Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and President, CEO in CADENCE PHARMACEUTICALS INC ($CADX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Otonomy, Inc. ($OTIC) and in Cidara Therapeutics, Inc. ($CDTX) and Director in Cidara Therapeutics, Inc. ($CDTX) and Chief Executive Officer in Nabriva Therapeutics plc ($NBRV) and Chief Executive Officer) in Nabriva Therapeutics plc ($NBRV).
Latest Insider Trading Transactions of Theodore R Schroeder
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CADX, CDTX, COLL, HPTX, NBRV, OTIC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.49 | 225 | 335 | 178,203 | 178.4 K to 178.2 K (-0.13 %) |
| May 04 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.78 | 107 | 190 | 178,428 | 178.5 K to 178.4 K (-0.06 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.73 | 225 | 389 | 178,535 | 178.8 K to 178.5 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.79 | 225 | 403 | 178,760 | 179 K to 178.8 K (-0.13 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.90 | 2,695 | 7,816 | 178,985 | 181.7 K to 179 K (-1.48 %) |
| Apr 08 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.90 | 2,695 | 7,816 | 178,985 | 181.7 K to 179 K (-1.48 %) |
| Apr 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.66 | 107 | 178 | 181,680 | 181.8 K to 181.7 K (-0.06 %) |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 2.62 | 125 | 328 | 181,893 | 182 K to 181.9 K (-0.07 %) |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 117,500 | 0 | 182,018 | 64.5 K to 182 K (+182.12 %) |
| Oct 01 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.53 | 1,211 | 645 | 648,818 | 650 K to 648.8 K (-0.19 %) |
| Sep 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.62 | 1,211 | 750 | 650,029 | 651.2 K to 650 K (-0.19 %) |
| Aug 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.76 | 1,211 | 920 | 651,240 | 652.5 K to 651.2 K (-0.19 %) |
| Jul 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.67 | 1,211 | 817 | 652,451 | 653.7 K to 652.5 K (-0.19 %) |
| Jun 25 2020 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Option Exercise | A | 3.97 | 17,500 | 69,475 | 17,500 | ||
| Jun 25 2020 | OTIC | OTONOMY, INC. | Schroeder Theodore R | Director | Option Exercise | A | 3.56 | 17,500 | 62,300 | 17,500 | |
| Jun 03 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.14 | 1,211 | 1,381 | 653,662 | 654.9 K to 653.7 K (-0.18 %) |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
| May 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.55 | 1,211 | 664 | 648,686 | 649.9 K to 648.7 K (-0.19 %) |
| Apr 02 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 0.58 | 1,211 | 696 | 649,897 | 651.1 K to 649.9 K (-0.19 %) |
| Mar 03 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.35 | 1,211 | 1,635 | 651,108 | 652.3 K to 651.1 K (-0.19 %) |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 1.35 | 687,500 | 928,125 | 687,500 | |
| Feb 10 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 343,800 | 0 | 646,560 | 302.8 K to 646.6 K (+113.56 %) |
| Feb 04 2020 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Payment of Exercise | F | 1.35 | 16,276 | 21,973 | 302,760 | 319 K to 302.8 K (-5.10 %) |
| Aug 28 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Buy | P | 1.79 | 50,000 | 89,500 | 117,489 | 67.5 K to 117.5 K (+74.09 %) |
| Jul 25 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 6,748 | 0 | 67,489 | 60.7 K to 67.5 K (+11.11 %) |
| Jun 27 2019 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 1.60 | 11,000 | 17,600 | 11,000 | |
| Jun 13 2019 | OTIC | OTONOMY, INC. | Schroeder Theodore R | Director | Option Exercise | A | 2.35 | 17,500 | 41,125 | 17,500 | |
| Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
| Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 163,250 | 0 | 163,250 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 429,800 | 0 | 429,800 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 850,000 | 0 | 850,000 | |
| Jun 20 2018 | OTIC | OTONOMY, INC. | Schroeder Theodore R | Director | Option Exercise | A | 4.45 | 17,500 | 77,875 | 17,500 | |
| Jun 15 2018 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
| May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
| May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
| Jul 14 2017 | OTIC | OTONOMY, INC. | Schroeder Theodore R | Director | Option Exercise | A | 16.05 | 15,000 | 240,750 | 15,000 | |
| Jun 23 2017 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 6.90 | 11,000 | 75,900 | 11,000 | |
| May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
| Jun 24 2016 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 10.22 | 9,000 | 91,980 | 9,000 | |
| Jun 21 2016 | OTIC | Otonomy, Inc. | Schroeder Theodore R | Director | Option Exercise | A | 15.20 | 15,000 | 228,000 | 15,000 | |
| Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
| Jan 26 2016 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 17.06 | 15,000 | 255,900 | 15,000 | |
| Sep 01 2015 | OTIC | Otonomy, Inc. | Schroeder Theodore R | Director | Option Exercise | A | 23.50 | 25,000 | 587,500 | 25,000 | |
| Jun 11 2015 | CDTX | Cidara Therapeutic ... | Schroeder Theodore R | Director | Option Exercise | A | 15.91 | 9,000 | 143,190 | 9,000 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Schroeder Theodore R | Director | Option Exercise | D | 24.57 | 6,800 | 167,076 | 0 | |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Schroeder Theodore R | Director | Sell | D | 46.00 | 3,083 | 141,818 | 0 | 3.1 K to 0 (-100.00 %) |
| May 08 2015 | HPTX | HYPERION THERAPEUT ... | Schroeder Theodore R | Director | Sell | U | 46.00 | 617 | 28,382 | 0 | 617 to 0 (-100.00 %) |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 0.00 | 400,000 | 0 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 5.40 | 400,000 | 2,160,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 3.51 | 164,074 | 575,900 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 3.51 | 350,000 | 1,228,500 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 8.55 | 500,000 | 4,275,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 9.22 | 150,000 | 1,383,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 9.22 | 35,000 | 322,700 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 8.35 | 200,000 | 1,670,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 6.01 | 400,000 | 2,404,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 15.13 | 100,000 | 1,513,000 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | D | 1.36 | 510,935 | 694,872 | 0 | |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | U | 14.00 | 307,500 | 4,305,000 | 0 | 307.5 K to 0 (-100.00 %) |
| Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | U | 14.00 | 12,664 | 177,296 | 0 | 12.7 K to 0 (-100.00 %) |
| Feb 12 2014 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
| Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 5.40 | 400,000 | 2,160,000 | 400,000 | |
| Mar 16 2012 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 3.51 | 164,074 | 575,900 | 164,074 | |
| Mar 16 2012 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 3.51 | 350,000 | 1,228,500 | 350,000 | |
| Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Payment of Exercise | F | 5.72 | 7,336 | 41,962 | 12,664 | 20 K to 12.7 K (-36.68 %) |
| Nov 04 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Buy | M | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| May 17 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Buy | P | 7.48 | 16,000 | 119,626 | 307,500 | 291.5 K to 307.5 K (+5.49 %) |
| Mar 18 2011 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 8.55 | 500,000 | 4,275,000 | 500,000 | |
| Oct 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 8.35 | 9,297 | 77,670 | 311,000 | 320.3 K to 311 K (-2.90 %) |
| Oct 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 8.35 | 40,703 | 339,691 | 320,297 | 361 K to 320.3 K (-11.28 %) |
| Jul 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 6.95 | 8,979 | 62,401 | 361,000 | 370 K to 361 K (-2.43 %) |
| Jul 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 7.00 | 41,021 | 287,250 | 369,979 | 411 K to 370 K (-9.98 %) |
| Apr 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.03 | 21,997 | 198,626 | 411,000 | 433 K to 411 K (-5.08 %) |
| Apr 01 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.30 | 28,003 | 260,330 | 432,997 | 461 K to 433 K (-6.07 %) |
| Mar 29 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 9.22 | 35,000 | 322,700 | 185,000 | |
| Mar 29 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 9.22 | 150,000 | 1,383,000 | 150,000 | |
| Jan 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.80 | 10,343 | 101,363 | 461,000 | 471.3 K to 461 K (-2.19 %) |
| Jan 04 2010 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 9.76 | 19,657 | 191,866 | 471,343 | 491 K to 471.3 K (-4.00 %) |
| Oct 19 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Sell | S | 10.72 | 20,000 | 214,376 | 491,000 | 511 K to 491 K (-3.91 %) |
| Sep 02 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Mar 20 2009 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 8.35 | 200,000 | 1,670,000 | 200,000 | |
| Mar 20 2008 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 6.01 | 400,000 | 2,404,000 | 400,000 | |
| Feb 22 2008 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Grant | A | 5.34 | 11,000 | 58,740 | 511,000 | 500 K to 511 K (+2.20 %) |
| Mar 26 2007 | CADX | CADENCE PHARMACEUT ... | Schroeder Theodore R | President, CEO | Option Exercise | A | 15.13 | 100,000 | 1,513,000 | 100,000 |
Page: 1